SCHEMBL6977075

SCHEMBL6977075

CCOC(=O)C(C)(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.48
MAPT P10636 4/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
CYP1A2 P05177 3/20 0.46
LMNA P02545 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CHRM4 P08173 2/20 0.45
CHRM1 P11229 2/20 0.45
CHRM3 P20309 2/20 0.45
CHRM5 P08912 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 3/20 0.44
GAA P10253 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
TRPV1 Q8NER1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1626657 0.86 CNR2 (0.48) MAPTKMT2AMEN1CYP1A2LMNA
SCHEMBL19183403 0.84 MAPT (0.49) MAPTKMT2AMEN1CYP1A2LMNA
SCHEMBL833293 0.84 CHRM2 (0.65) CHRM2MAPTKMT2ACYP1A2LMNA
SCHEMBL2396473 0.82 MAPT (0.50) MAPTKMT2AMEN1CYP1A2LMNA
SCHEMBL29156932 0.81 CHRM2 (0.64) CHRM2CYP2C19NPSR1CHRM4CHRM1
SCHEMBL22164189 0.81 MAPT (0.46) MAPTKMT2AMEN1CYP1A2LMNA
SCHEMBL11844527 0.80 MAPT (0.43) MAPTKMT2AMEN1CYP1A2LMNA
Hydrochloric Acid SCHEMBL17825610 0.80 MAPT (0.43) MAPTKMT2AMEN1CYP1A2LMNA
SCHEMBL29571318 0.80 MAPT (0.46) MAPTKMT2AMEN1CYP1A2LMNA
SCHEMBL17825606 0.79 MAPT (0.45) MAPTKMT2AMEN1CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322599-A2 HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-07-02 EP disclosed
WO-2001096283-A9 HIV INTEGRASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2002-10-17 WO disclosed
WO-2001096283-A2 HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-12-20 WO disclosed